Rho-kinase: important new therapeutic target in cardiovascular diseases
- 1 August 2011
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 301 (2) , H287-H296
Abstract
Rho-kinase (ROCKs) belongs to the family of serine/threonine kinases and is an important downstream effector of the small GTP-binding protein RhoA. There are two isoforms of Rho-kinase, ROCK1 and ROCK2, and they have different functions with ROCK1 for circulating inflammatory cells and ROCK2 for vascular smooth muscle cells. It has been demonstrated that the RhoA/Rho-kinase pathway plays an important role in various fundamental cellular functions, including contraction, motility, proliferation, and apoptosis, leading to the development of cardiovascular disease. The important role of Rho-kinase in vivo has been demonstrated in the pathogenesis of vasospasm, arteriosclerosis, ischemia-reperfusion injury, hypertension, pulmonary hypertension, stroke, and heart failure. Furthermore, the beneficial effects of fasudil, a selective Rho-kinase inhibitor, have been demonstrated for the treatment of several cardiovascular diseases in humans. Thus the Rho-kinase pathway is an important new therapeutic target in cardiovascular medicine.Keywords
This publication has 142 references indexed in Scilit:
- Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular diseaseTrends in Pharmacological Sciences, 2011
- Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E–deficient miceJournal of Experimental Medicine, 2010
- Oxidative Stress and Vascular Smooth Muscle Cell Growth: A Mechanistic Linkage by Cyclophilin AAntioxidants & Redox Signaling, 2010
- Age-Related Changes in Redox Signaling and VSMC FunctionAntioxidants & Redox Signaling, 2010
- Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II–induced aortic aneurysmsNature Medicine, 2009
- Mechanism of multi‐site phosphorylation from a ROCK‐I:RhoE complex structureThe EMBO Journal, 2008
- Cyclophilin A produced by thymocytes regulates the migration of murine bone marrow cellsCellular Immunology, 2007
- Rho Kinase (ROCK) InhibitorsJournal of Cardiovascular Pharmacology, 2007
- New Roles of Myosin II during Vesicle Transport and Fusion in Chromaffin CellsJournal of Biological Chemistry, 2004
- Inflammation in atherosclerosisNature, 2002